RESEARCH
For the first time, the EPA has flagged microplastics and pharmaceuticals as priority drinking water contaminants
8 May 2026

America's drinking water has carried microplastics and prescription drug residues for years. Washington is only now starting to officially care.
On April 2, 2026, EPA released its draft Sixth Contaminant Candidate List, designating microplastics and pharmaceuticals as priority contaminant groups under the Safe Drinking Water Act. Neither had previously held formal federal research status under drinking water law. That changes now.
Real money came with the announcement. A new federal program called STOMP will direct $144 million toward studying microplastics in human tissue, the largest coordinated US investment in emerging drinking water contaminants in recent memory. EPA also released health benchmarks for 374 pharmaceutical compounds, giving water utilities a scientific baseline for evaluating drug residues in their source water.
None of this happened in a vacuum. Seven state governors had already petitioned EPA to include microplastics under the Unregulated Contaminant Monitoring Rule, which requires public water systems to screen for specified substances nationwide. With CCL 6 designation confirmed, that outcome looks increasingly likely.
Science still has some catching up to do. No agreed-upon definition for microplastics in drinking water currently exists, and standardized testing protocols remain a work in progress. How quickly those gaps close will determine when utilities face hard compliance deadlines.
For water treatment operators and technology developers, regulatory direction is unmistakable. Advanced membrane filtration, electrochemical oxidation, and enhanced coagulation are all drawing new research interest as removal candidates. Utilities that review their treatment systems now will be better positioned for whatever comes next. Public comments close June 5, 2026, with final publication expected by November. That window is open.
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.